B-Right RealEstate Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 2:43 pm

Quick Insight

B-Right RealEstate Ltd, a company in the Construction, Contracting & Engineering industry, demonstrates a high P/E ratio of 120, indicating a potentially overvalued stock compared to its earnings. With an ROE of 1.58% and ROCE of 5.08%, the company's profitability and capital efficiency seem relatively low. However, B-Right RealEstate boasts a healthy operating profit margin of 11% and a respectable Interest Coverage Ratio (ICR) of 6.59x, suggesting it can comfortably meet its interest obligations. The significant promoter holding of 71.92% instills confidence in the company's future prospects, although the lack of FII and DII holdings may raise questions about broader market sentiment. In conclusion, investors should carefully assess the company's growth potential and financial health before considering an investment in B-Right RealEstate Ltd.

Competitors of B-Right RealEstate Ltd

All Competitor Stocks of B-Right RealEstate Ltd

Quarterly Result

Last Updated: July 16, 2025, 12:55 pm

Below is a detailed analysis of the quarterly data for B-Right RealEstate Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Sep 2024) to 63.00 Cr., marking an increase of 22.00 Cr..
• For Expenses, as of Mar 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Sep 2024) to 56.00 Cr., marking an increase of 22.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Sep 2024) to 7.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Mar 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Sep 2024) to 11.00%, marking a decrease of 4.00%.
• For Other Income, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -2.00 Cr. (Sep 2024) to 1.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Sep 2024) to 6.00 Cr., marking an increase of 3.00 Cr..
• For Tax %, as of Mar 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 99.00% (Sep 2024) to 23.00%, marking a decrease of 76.00%.
• For Net Profit, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 4.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 1.08. The value appears strong and on an upward trend. It has increased from 0.55 (Sep 2024) to 1.08, marking an increase of 0.53.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:42 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:46 pm

Below is a detailed analysis of the balance sheet data for B-Right RealEstate Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 131.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2024) to 131.00 Cr., marking an increase of 2.00 Cr..
• For Borrowings, as of Mar 2025, the value is 78.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 154.00 Cr. (Mar 2024) to 78.00 Cr., marking a decrease of 76.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 112.00 Cr.. The value appears to be improving (decreasing). It has decreased from 151.00 Cr. (Mar 2024) to 112.00 Cr., marking a decrease of 39.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 332.00 Cr.. The value appears to be improving (decreasing). It has decreased from 445.00 Cr. (Mar 2024) to 332.00 Cr., marking a decrease of 113.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2024) to 28.00 Cr., marking a decrease of 15.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Mar 2025, the value is 286.00 Cr.. The value appears to be declining and may need further review. It has decreased from 387.00 Cr. (Mar 2024) to 286.00 Cr., marking a decrease of 101.00 Cr..
• For Total Assets, as of Mar 2025, the value is 332.00 Cr.. The value appears to be declining and may need further review. It has decreased from 445.00 Cr. (Mar 2024) to 332.00 Cr., marking a decrease of 113.00 Cr..

Notably, the Reserves (131.00 Cr.) exceed the Borrowings (78.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for B-Right RealEstate Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 5. It has decreased from 2.35 (Mar 24) to 1.64, marking a decrease of 0.71.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 5. It has decreased from 2.35 (Mar 24) to 1.64, marking a decrease of 0.71.
• For Cash EPS (Rs.), as of Mar 25, the value is 5.49. This value is within the healthy range. It has decreased from 6.46 (Mar 24) to 5.49, marking a decrease of 0.97.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 136.71. It has decreased from 138.96 (Mar 24) to 136.71, marking a decrease of 2.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 136.71. It has decreased from 138.96 (Mar 24) to 136.71, marking a decrease of 2.25.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 100.11. It has increased from 39.58 (Mar 24) to 100.11, marking an increase of 60.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.07. This value is within the healthy range. It has increased from 10.84 (Mar 24) to 14.07, marking an increase of 3.23.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.81. This value is within the healthy range. It has increased from 9.53 (Mar 24) to 12.81, marking an increase of 3.28.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.12. This value is within the healthy range. It has decreased from 8.36 (Mar 24) to 8.12, marking a decrease of 0.24.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.23. This value is within the healthy range. It has decreased from 5.15 (Mar 24) to 4.23, marking a decrease of 0.92.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 2. It has decreased from 2.35 (Mar 24) to 1.64, marking a decrease of 0.71.
• For PBDIT Margin (%), as of Mar 25, the value is 14.05. This value is within the healthy range. It has decreased from 27.38 (Mar 24) to 14.05, marking a decrease of 13.33.
• For PBIT Margin (%), as of Mar 25, the value is 12.79. This value is within the healthy range. It has decreased from 24.08 (Mar 24) to 12.79, marking a decrease of 11.29.
• For PBT Margin (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 10. It has decreased from 21.11 (Mar 24) to 8.10, marking a decrease of 13.01.
• For Net Profit Margin (%), as of Mar 25, the value is 4.22. This value is below the healthy minimum of 5. It has decreased from 13.01 (Mar 24) to 4.22, marking a decrease of 8.79.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.63. This value is below the healthy minimum of 8. It has decreased from 5.94 (Mar 24) to 1.63, marking a decrease of 4.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 15. It has decreased from 1.74 (Mar 24) to 1.19, marking a decrease of 0.55.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
• For Return On Assets (%), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 5. It has decreased from 0.54 (Mar 24) to 0.51, marking a decrease of 0.03.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.26. This value is within the healthy range. It has decreased from 0.30 (Mar 24) to 0.26, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.55. This value is within the healthy range. It has decreased from 1.10 (Mar 24) to 0.55, marking a decrease of 0.55.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.26. It has increased from 0.11 (Mar 24) to 0.26, marking an increase of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 1.77. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 1.77, marking an increase of 0.42.
• For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.57 (Mar 24) to 1.08, marking an increase of 0.51.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 4. It has decreased from 0.30 (Mar 24) to 0.29, marking a decrease of 0.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.59. This value is within the healthy range. It has decreased from 9.24 (Mar 24) to 6.59, marking a decrease of 2.65.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.18. This value is within the healthy range. It has decreased from 5.39 (Mar 24) to 4.18, marking a decrease of 1.21.
• For Enterprise Value (Cr.), as of Mar 25, the value is 459.97. It has increased from 320.25 (Mar 24) to 459.97, marking an increase of 139.72.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.45. This value exceeds the healthy maximum of 3. It has decreased from 7.83 (Mar 24) to 4.45, marking a decrease of 3.38.
• For EV / EBITDA (X), as of Mar 25, the value is 31.64. This value exceeds the healthy maximum of 15. It has increased from 28.59 (Mar 24) to 31.64, marking an increase of 3.05.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.65. This value exceeds the healthy maximum of 3. It has decreased from 4.07 (Mar 24) to 3.65, marking a decrease of 0.42.
• For Price / BV (X), as of Mar 25, the value is 2.68. This value is within the healthy range. It has increased from 1.19 (Mar 24) to 2.68, marking an increase of 1.49.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.65. This value exceeds the healthy maximum of 3. It has decreased from 4.07 (Mar 24) to 3.65, marking a decrease of 0.42.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness